Sutton, United Kingdom

Richard Knox



Average Co-Inventor Count = 5.9

ph-index = 3

Forward Citations = 30(Granted Patents)


Location History:

  • Sutton, GB (1997 - 1999)
  • Belmont Sutton, GB (1999)

Company Filing History:


Years Active: 1997-1999

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Richard Knox: Innovator in Cancer Research

Introduction

Richard Knox is a notable inventor based in Sutton, GB. He has made significant contributions to the field of cancer research, holding a total of 4 patents. His work focuses on innovative approaches to cancer treatment, particularly through the development of prodrugs and gene-prodrug systems.

Latest Patents

Among his latest patents is the "Bacterial nitroreductase for the reduction of CB1954 and analogues." This patent describes a prodrug of a specific formula where R¹ is a group that allows the compound R¹ NH₂ to represent actinomycin D, doxorubicin, mitomycin C, or a nitrogen mustard. Another significant patent is the "Bacterial nitroreductase gene-prodrug system," which outlines processes for creating prodrugs by reacting a prodrug precursor compound with 4-nitrobenzyl chloroformate under anhydrous conditions.

Career Highlights

Richard Knox is currently associated with Cancer Research Campaign Technology Limited, where he continues to advance his research and innovations in cancer treatment. His work has the potential to significantly impact therapeutic strategies in oncology.

Collaborations

He has collaborated with notable colleagues such as Roger Sherwood and Thomas Connors, contributing to a dynamic research environment focused on cancer therapies.

Conclusion

Richard Knox's innovative work in cancer research exemplifies the importance of scientific advancements in improving treatment options. His patents and collaborations highlight his commitment to finding effective solutions in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…